May 15, 2024 8:00 am EDT Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
Apr 15, 2024 9:15 am EDT Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
Apr 11, 2024 9:45 am EDT Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
Mar 20, 2024 8:30 am EDT Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
Mar 19, 2024 4:10 pm EDT Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
Mar 8, 2024 9:00 am EST Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
Feb 22, 2024 8:00 am EST Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
